04/14/2014 | Mark Hillen
In many patients, glaucoma cannot be controlled with eyedrops, but a range of surgical techniques and drainage devices can help.
Predictors for primary open-angle glaucoma in a South Indian population.
04/13/2014 | Mark Hillen
Subcutaneously-administrated IL-18 works well to reverse choroidal neovascularization (in mice).
An advanced level of statistical knowledge is necessary to critically appraise most ophthalmology literature.
More money-saving combinations of smartphones and snap-on adapters that enable you to perform eye examinations on-the-go.
03/13/2014 | Mark Hillen
If you’re a retina specialist, you’ll be more likely than not to see patients with diabetic macular edema (DME) on a daily basis. Lasers and anti-VEGF therapy have transformed outcomes within a generation
03/12/2014 | Mark Hillen
Making an optimal eyedrop formulation has always been a major challenge; compromises had to be made. Nanodroplet emulsion technology has changed that. Here’s how.
03/11/2014 | Mark Hillen
What does analysis of the last five years of literature on glaucoma tell us about the priorities of the field and the major contributors to it?
03/10/2014 | Mark Hillen
Although baby boomers may be in a state of denial regarding their own aging, ophthalmologists know differently. In particular, four diseases of the ageing eye comprise a demographic and economic timebomb.
Aflibercept gets approved by NICE, STAAR’s Visian ICL with CentraFLOW gets approved in Japan, and rises and falls in Allergan and Alcon’s revenues.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: